LISAvienna #REG25: Diskussionen am Puls der Zeit und praxisrelevante Tipps Am 15. Oktober 2025 fand in Wien die neunte Konferenz von LISAvienna mit Fokus auf regulatorische Fragen rund um den Marktzugang von Medizinprodukten und In-vitro Diagnostika statt.

#REG25 Rückblick: Einblicke in strategisch aufgesetzte Markteintrittsstrategien für Medizinprodukte und in-vitro Diagnostika, den Nutzen von KI, Tipps zum Thema Cybersecurity, die Bedeutung von Real World Data und Real World Evidence sowie lehrreiche Praxisbeispiele.
www.linkedin.com/pulse/lisavi...

#reg25 #reg | LISAvienna ✨ What a day at #REG25 in Vienna! ✨ Yesterday’s LISAvienna Regulatory Affairs Conference for Medical Devices and In-vitro Diagnostics was a fantastic success — full of expert insights, engaging discu...

Yesterday's LISAvienna Regulatory Affairs Conference for Medical Devices and In-vitro Diagnostics #REG25 in Vienna was a fantastic success — a huge thank-you to all speakers for their excellent contributions and to all participants for their active engagement!
www.linkedin.com/feed/update/...

#reg25 #mdr #ivdr | LISAvienna We’re getting ready for the LISAvienna Regulatory Affairs Conference for Medical Devices and In-vitro Diagnostics #REG25 in Vienna! Here’s what to look forward to: - A keynote on smart regulatory st...

We can’t wait to welcome you at our #REG25 conference at Apothekertrakt, Schönbrunn Palace, tomorrow!

www.linkedin.com/feed/update/...

#reg25 | LISAvienna #REG25 coffee break sponsor alert: medikus medizintechnische und pharmazeutische Vertriebs GmbH - business unit SteriMedix Learn more about the company’s portfolio of services for first-class medical...

medikus medizintechnische und pharmazeutische Vertriebs GmbH | business unit SteriMedix to sponsor the coffee break at LISAvienna's #REG25 conference on October 15, 2025. Thank you for your support!

Registration is open until October 8 - see you in Vienna next week. www.linkedin.com/feed/update/...

#reg25 | LISAvienna #REG25 session alert: A3: Reimbursement of digital health applications across Europe We are looking forward to this session at the LISAvienna Regulatory Affairs Conference for Medical Devices and In ...

Learn more about the reimbursement of digital health applications across Europe at LISAvienna's #REG25 conference, Vienna, 15.10.2025 - Session A3 with AIHTA, IHS, HelloBetter, AUSTROMED
www.linkedin.com/posts/lisavi...

LISAvienna #REG25: Register now! LISAvienna cordially invites you to attend the ninth Regulatory Affairs Conference for Medical Devices and In Vitro Diagnostics, taking place on October 15, 2025, in Vienna. Register now!

Over 220 participants from more than 130 organizations have already registered for #REG25! Join us in Vienna on 15.10. for an update on MDR, IVDR, etc.
Startups: This a door-opener to the regulatory universe, especially if your product’s classification isn’t yet clear. mailchi.mp/lisavienna/r...

#reg25 | LISAvienna #REG25 session alert: A1: Software tools for supporting regulatory affairs We are looking forward to a panel discussion on this topic at the LISAvienna Regulatory Affairs Conference for Medical Devic...

We are looking forward to a panel discussion on software tools for supporting regulatory affairs at #REG25, Oct 15 in Vienna
- Alexander Fink, Metecon
- Sophie Pingitzer, XUND
- Birgit Wahlmüller, MADx
- Andreas Weinfurter, ACMIT
Moderation: Martin Schmid, en.co.tec
www.linkedin.com/feed/update/...

#reg25 | LISAvienna #REG25 session alert: B1: Leverage real-world data for your clinical development We are looking forward to this session at the LISAvienna Regulatory Affairs Conference for Medical Devices and In Vitr...

Learn more about leveraging real-world data for clinical development of MD at #REG25, 15.10. in Vienna:
Ghazaleh Gouya: How to use RWD for generating clinical evidence
Camille Petri: The Notified Body’s perspective
Katarzyna Malenczyk: Lessons from mySugr's PMCF plan
www.linkedin.com/feed/update/...

#reg25 #mdr #ivdr | LISAvienna #REG25 session alert: B3: From theory to reality: Practical approaches and regulatory framework in EU and U.S. We are looking forward to this session at the LISAvienna Regulatory Affairs Conference f...

15.10. #REG25: From theory to reality
- Friederike Windisch | Nina Zimmermann @goeg.at: Transition to MDR/IVDR: status quo of economic operators
- Monika Hupfauf | Martin Popovic: Regulatory Fork in the Road: US or EU First? Pros and Cons
www.linkedin.com/feed/update/...

#reg25 #ai | LISAvienna #REG25 session alert: A2: Regulatory aspects around trustworthy #AI We are looking forward to this session at the LISAvienna Regulatory Affairs Conference for Medical Devices and In Vitro Diagnostics...

15.10.2025: #REG25 in Vienna | Sssion A2: Regulatory aspects around trustworthy #AI
- 11:00 Ali Moshayedi, BSI: Compliance and Trust Under The EU AI Act
- 11:40 Diether Kramer, Predicting Health: Mind the Risk: Bringing Clinical Risk Prediction into Compliance.
www.linkedin.com/feed/update/...

#reg25 #ivds | LISAvienna #REG25 session alert: B2: Session on regulatory aspects around #IVDs We are looking forward to this session at the LISAvienna Regulatory Affairs Conference for Medical Devices and In Vitro Diagnostic...

Learn more about regulatory aspects associated with IVD at LISAvienna's #REG25 conference, 15.10.2025, in Vienna:
- QMD Services: Overcoming certification hurdles
- MedUni Vienna: Best practice on in-house IVDs
- MADx: Lessons learned from a company's perspective
www.linkedin.com/feed/update/...

LISAvienna #REG25: Partnering is open LISAvienna cordially invites you to attend the ninth Regulatory Affairs Conference for Medical Devices and In Vitro Diagnostics, taking place on October 15, 2025, in Vienna. Partnering is now open - r...

LISAvienna Regulatory Affairs Conference for Medical Devices and In-vitro Diagnostics, Vienna, 15.10.2025: Partnering is now open: Start to request 20-minute-meetings with conference participants to boost your network at #REG25!
mailchi.mp/lisavienna/r...

#REG25 session alert: C1: Cybersecurity and IT security | LISAvienna #REG25 session alert: C1: Cybersecurity and IT security We are looking forward to this session at the LISAvienna Regulatory Affairs Conference for Medical Devices and In Vitro Diagnostics, October 15...

Learn more about cybersecurity and IT security for medical devices - Larissa Naber (Proregia), Tina Vodopivec (SIQ Ljubljana), and Nilaykumar Patel (contextflow) will provide insights at this year's #REG25 conference in Vienna. Register by 8.8. to save costs!
www.linkedin.com/posts/lisavi...

#REG25 session alert: C2 Post market surveillance and periodic safety update report (#PSUR) | LISAvienna #REG25 session alert: C2 Post market surveillance and periodic safety update report (#PSUR) We are looking forward to this session at the LISAvienna Regulatory Affairs Conference for Medical Devices ...

Learn more about post market surveillance und PSUR at LISAvienna's #REG25 conference on October 15 in Vienna! Early bird rates are still available until August 8. More than 160 participants have already registered. Partnering request will be possible as of August 18.
www.linkedin.com/feed/update/...

#REG25 session alert: C3 Classification of medical devices | LISAvienna #REG25 session alert: C3 Classification of medical devices We are looking forward to this session at the LISAvienna Regulatory Affairs Conference for Medical Devices and In Vitro Diagnostics, October...

Learn more about the classification of medical devices and IVD at our #REG25 conference, 15.10.2025 in Vienna.
www.linkedin.com/feed/update/...

The Medical Device Regulation (#MDR) and In Vitro Diagnostic Regulation (#IVDR) are key pillars in enhancing patient safety across the EU. | LISAvienna The Medical Device Regulation (#MDR) and In Vitro Diagnostic Regulation (#IVDR) are key pillars in enhancing patient safety across the EU. By ensuring that only safe, effective, and high-quality medic...

Join Martin Schmid, en.co.tec, at #REG25 for an update on #MDR and #IVDR. He explores the tensions between market shakeout and regulatory postponement, and discusses how the medtech industry can – and should – respond to the evolving regulatory landscape.
www.linkedin.com/feed/update/...

We’re looking forward to the #REG25 keynote lecture by Maria Agustina Duguine Carrasco, AF Pharma Serivce on smart regulatory strategies for cost-effective market entry. | LISAvienna We’re looking forward to the #REG25 keynote lecture by Maria Agustina Duguine Carrasco, AF Pharma Serivce on smart regulatory strategies for cost-effective market entry. Join us and grow your network!...

Interested in smart regulatory strategies for cost-effective market entry of medical devices and IVD? Join #REG25 on October 15, 2025 in Vienna!
www.linkedin.com/feed/update/...

🎯 We’re thrilled by the strong interest in the LISAvienna Regulatory Affairs Conference for Medical Devices and In-vitro Diagnostics! | LISAvienna 🎯 We’re thrilled by the strong interest in the LISAvienna Regulatory Affairs Conference for Medical Devices and In-vitro Diagnostics! 💡 Early bird rates are available until August 8, 2025 – don’t mi...

Early bird rates for #REG25 are available until August 8.
- Want to send a larger team? We have a 5+1 offer
- Startups: Our conference is a door-opener to the regulatory universe. Don't miss out!
www.linkedin.com/feed/update/...

Join us at #REG25 in Vienna: LISAvienna cordially invites you to attend the ninth Regulatory Affairs Conference for Medical Devices and In Vitro Diagnostics, taking place on October 15, 2025, in… | LI... Join us at #REG25 in Vienna: LISAvienna cordially invites you to attend the ninth Regulatory Affairs Conference for Medical Devices and In Vitro Diagnostics, taking place on October 15, 2025, in Vienn...

Register now to join our LISAvienna Regulatory Affairs Conference for Medical Devices and In-vitro Diagnostics on October 15, 2025 in Vienna!
#REG25
www.linkedin.com/feed/update/...

LISAvienna Regulatory Affairs Conference 2025 LISAvienna invites you to attend the ninth Regulatory Affairs Conference for Medical Devices and In Vitro Diagnostics on October 15, 2025, in Vienna.

#REG25: The first 50 participants have already registered! Join us for your update on MDR, IVDR, DiGA reimbursement in Austria and Europe, leveraging real world data for clinical dev, AI, PMS etc. Early bird tickets are available until 25.7.2025.
www.b2match.com/e/lisavienna...